Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Naturally Occurring Antibodies May Lead to New RA Therapies

From the College  |  Issue: December 2010  |  December 1, 2010

A study published in the Journal of Immunology indicates that naturally occurring antibodies in the human immune system have the capacity to suppress inflammatory responses throughout the body.1 These antibodies may provide researchers an opportunity to develop new therapies for rheumatoid arthritis (RA) and other inflammatory conditions using similar pathways.

The lead researcher of this ongoing work, Gregg J. Silverman, MD, of the University of California, San Diego School of Medicine, is a recipient of an ACR Research and Education Foundation (REF) Within Our Reach: Finding a Cure for Rheumatoid Arthritis research grant.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Gregg J. Silverman, MDWe’re trying to bottle a little bit of Mother Nature that will help get people back into balance.

—Gregg J. Silverman, MD

“Following different clues, we have discovered that the human immune system contains naturally occurring antibodies that have the ability to down-regulate inflammatory response from the more primitive innate immune system,” Dr. Silverman says. “What this means is that this ancient innate part of our immune system is meant to respond dramatically, quickly, and vigorously to any kind of foreign threat. These are meant to attack infectious agents. The problem is when that same response becomes dysregulated and over-exuberant, it becomes one of the most destructive aspects of autoimmune diseases, including rheumatoid arthritis,” he notes.

“The good news,” continues Dr. Silverman, “is that these antibodies also can suppress inflammation. We think we can use these antibodies to provide a targeted approach to suppress inflammation by pathways that appear to be very similar to those of corticosteroids, which are the most commonly used immunosuppressive agents for rheumatic and inflammatory diseases.”

But unlike corticosteroids, potential therapies using these natural antibodies would be much less likely to have serious side effects.

“It’s absolutely unexpected that we’ve been able to show very powerful properties equivalent to the strongest doses of corticosteroids while using very low levels of these natural occurring antibodies,” Dr. Silverman says. “We’re trying to bottle a little bit of Mother Nature that will help get people back into balance.”

Support Research

To make a pledge or one-time donation to the REF for the Within Our Reach: Finding a Cure for Rheumatoid Arthritis campaign, visit www.rheumatology.org/REF. For more information about the Within Our Reach campaign and to read about the grant projects, visit www.WithinOurReach.info.

Dr. Silverman says that thus far this research has been focused primarily in mice, but the investigators have found remarkable parallels between the mouse immune system and the human immune system.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Page: 1 2 | Single Page
Share: 

Filed under:ConditionsFrom the CollegeResearch RheumRheumatoid Arthritis Tagged with:AntibodiesBasic researchRAREF NewsRheumatoid arthritis

Related Articles

    A Look Back & A Look Ahead: ACR Research and Education Foundation Turns 25

    August 1, 2010

    The ACR Research and Education Foundation turns 25

    Rheumatology’s Architect

    March 1, 2008

    Help the REF lay foundations for our future

    Productive Partnership

    August 1, 2009

    The ACR and the REF work closely to support the future of rheumatology

    To Understand Lupus, Study the Gut

    September 17, 2019

    Researchers who devote their time to studying lupus are accustomed to considering environmental stimuli such as sunshine and cigarettes. But according to Gregg J. Silverman, MD, a professor in the Department of Medicine and in the Department of Pathology at the New York University (NYU) School of Medicine and co-director of the Musculoskeletal Center of…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences